Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning.

"all r codes used for analysis are deposited in github at https://github com/yiwangz/ss_learning/mlinhct ."

"Conflict-of-interest disclosure: A.S. has received consultant fees from Spotlight Therapeutics, Medexus Inc, Vertex Pharmaceuticals, Sangamo Therapeutics, and Editas Medicine; is a medical monitor for a Resource for Clinical Investigations in Blood and Marrow Transplantation (RCI BMT) clinical trial for which he receives financial compensation; received research funding from CRISPR Therapeutics and honoraria from Vindico Medical Education; and is also the St Jude Children’s Research Hospital site principal investigator for clinical trials of genome editing for sickle cell disease sponsored by Vertex Pharmaceuticals/CRISPR Therapeutics (NCT03745287), Novartis Pharmaceuticals (NCT04443907), and Beam Therapeutics (NCT05456880) (the industry sponsors provide funding for the clinical trials, which includes salary support paid to the investigator’s institution and A.S. has no direct financial interest in these therapies). The remaining authors declare no competing financial interests."

"Y.Z., J.S., D.C.S., C.L., Y.S., S.S.M., S.N., B.M.T., L.T., and A.S. are supported for their work at St Jude Children’s Research Hospital by the 10.13039/100012524American Lebanese Syrian Associated Charities and 10.13039/100000002National Institutes of Health/10.13039/100000054National Cancer Institute grant (P30 CA021765). R.S. was supported by a Memorial Sloan Kettering Cancer Center Core grant (P30 CA008748) from the 10.13039/100000002National Institutes of Health/10.13039/100000054National Cancer Institute."